95 related articles for article (PubMed ID: 4013657)
1. Further observations showing the impact of the probenecid test in movement disorders.
Vanderheyden JE; Dumont JP; Dekoninck WJ; Mendlewicz J
Acta Neurol Belg; 1985; 85(3):171-81. PubMed ID: 4013657
[TBL] [Abstract][Full Text] [Related]
2. [Value of the probenecid test in the diagnosis and treatment of parkinson disease].
Vanderheyden JE; Noel G; Mendlewicz J
Acta Neurol Belg; 1982; 82(6):339-52. PubMed ID: 7164768
[TBL] [Abstract][Full Text] [Related]
3. Biochemical aids in the diagnosis of Parkinson's disease.
Chase TN; Eng N; Gordon EK
Ann Clin Lab Sci; 1976; 6(1):4-10. PubMed ID: 1247283
[TBL] [Abstract][Full Text] [Related]
4. [Central metabolism of dopamine and serotonin. I. Determination of cerebrospinal fluid levels of HVA and 5-HIAA by the probenecid test (modified)].
Carrieri P; Campanella G; Mandarini A; Orefice G; Buscaino GA
Acta Neurol (Napoli); 1976; 31(5):558-64. PubMed ID: 1015382
[No Abstract] [Full Text] [Related]
5. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
[No Abstract] [Full Text] [Related]
6. [Use of the probenecid test for the diagnosis and treatment of Parkinsonism. Review of the literature and personal experience (author's transl)].
Vanderheyden JE; Dekoninck WJ; Lefèvre A; Mendlewicz J
Encephale; 1980; 6(4):349-66. PubMed ID: 6160034
[TBL] [Abstract][Full Text] [Related]
7. 14C-homovanillic acid in the cerebrospinal fluid of parkinsonian patients after intravenous 14C-L-dopa.
Extein I; Van Woert M; Roth RH; Bowers MB
Biol Psychiatry; 1976 Apr; 11(2):227-32. PubMed ID: 971447
[TBL] [Abstract][Full Text] [Related]
8. CSF homovanillic acid: an index of dopaminergic activity.
Curzon G
Adv Neurol; 1975; 9():349-57. PubMed ID: 125031
[TBL] [Abstract][Full Text] [Related]
9. [Approaches to the study of dopamine metabolism in various extrapyramidal diseases].
Barkhatova VP; Kandel' EI; Demina EG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(7):1021-9. PubMed ID: 6457476
[TBL] [Abstract][Full Text] [Related]
10. Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders.
Cramer H; Warter JM; Renaud B
Adv Neurol; 1984; 40():431-5. PubMed ID: 6198888
[No Abstract] [Full Text] [Related]
11. Homovanilic acid in Huntington's disease and Sydenham's chorea.
Cunha L; Oliveira CR; Diniz M; Amaral R; Conçalves AF; Pio-Abreu J
J Neurol Neurosurg Psychiatry; 1981 Mar; 44(3):258-61. PubMed ID: 6453208
[TBL] [Abstract][Full Text] [Related]
12. [Homovanillic acid content in the cerebrospinal fluid as an index of dopamine cerebral metabolism before and after a stereotaxic operation in patients with extrapyramidal hyperkinetic syndromes].
Barkhatova VP; Kandel' EI; Omorova TM; Demina EG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(7):1050-5. PubMed ID: 6382885
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid probenecid studies: a reinterpretation.
Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
[TBL] [Abstract][Full Text] [Related]
14. Apomorphine, pimozide, L-Dopa and the probenecid test in Huntington's chorea.
Lal S; De la Vega C; Garelis E; Sourkes TL
Psychiatr Neurol Neurochir; 1973; 76(2):113-7. PubMed ID: 4267059
[No Abstract] [Full Text] [Related]
15. The probenecid test in Parkinson's disease.
Lakke JP; Korf J; Hoorntje S; Schut T; van Praag HM
Psychiatr Neurol Neurochir; 1973; 76(2):139-46. PubMed ID: 4700931
[No Abstract] [Full Text] [Related]
16. Sydenham's chorea: a possible presynaptic dopaminergic dysfunction initially.
Naidu S; Narasimhachari N
Ann Neurol; 1980 Oct; 8(4):445-7. PubMed ID: 6159821
[TBL] [Abstract][Full Text] [Related]
17. [Lumbar cerebrospinal fluid levels of GABA, HVA and 5HIAA in various patients with choreic movement and effects with isoniazid treatment].
Yamamoto M; Otsuki S; Miyake K; Namba R
No To Shinkei; 1983 May; 35(5):483-8. PubMed ID: 6194804
[No Abstract] [Full Text] [Related]
18. A study of spinal fluid homovanillic acid (HVA) in patients with diseases of the nervous system.
Mones RJ; Wilk S; Green J; Jutkowitz R
Mt Sinai J Med; 1972; 39(5):478-85. PubMed ID: 4538762
[No Abstract] [Full Text] [Related]
19. HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movements.
Guilleminault C; Tharp BR; Cousin D
J Neurol Sci; 1973 Apr; 18(4):435-41. PubMed ID: 4540626
[No Abstract] [Full Text] [Related]
20. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
Seifert WE; Foxx JL; Butler IJ
Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
